A top insurer has announced restrictions on where its clients can purchase certain high-cost drugs — including the weight ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Use AARP’s interactive scam-tracking map to stay informed about ...

This is read by an automated voice. Please report any issues or inconsistencies here. The White House’s new TrumpRx platform launched Thursday, pledging dramatic prescription label price cuts for ...

The Trump administration finally has unveiled TrumpRx.gov, a website for consumers to find discounts on brand-name drugs if they pay cash instead of using their health insurance. It launched Thursday ...

Feb 5 (Reuters) - (This Feb 5 story has been corrected to fix Prolia's 2025 sales to $4.4 billion, not $1.05 billion, in paragraph 5) Sign up here. Its pharmacy benefit management unit, Caremark, will ...

CVS Caremark will begin offering osteoporosis biosimilars Ospomyv and Stoboclo, as well as generic teriparatide, Bonsity and Tymlos. Like Humira and its biosimilars, Prolia is a specialty drug ...

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. John Wilkerson is a ...

Cigna Corp's Express Scripts has settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at ...

The legislation will impose new restrictions on pharmacy benefit managers, giant companies like CVS Caremark, Optum Rx and Express Scripts that oversee prescription drug benefits. By Reed Abelson and ...